Media Kits
Media members may access multimedia resources such as fact sheets, infographics, photos, logos, select press releases and more, all for use in stories in development.
Neutralizing Antibodies for COVID-19
See More About Antibody Therapies
Baricitinib for COVID-19
See More About Baricitinib
Cyramza® (ramucirumab) Approved by the U.S. FDA as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Read More About Cyramza
Retevmo® (selpercatinib): First Therapy Specifically for Patients with Advanced RET-Driven Cancers Is Approved
Read More About Retevmo
Reyvow™ (lasmiditan) C-V: A First-in-Class Acute Treatment for Migraine Is Now Available
Read More About Reyvow